Download as pdf or txt
Download as pdf or txt
You are on page 1of 20

Assignment

On
Cipla Limited
2020-2021

Submitted for : Vasudha Sharma


Lecturer of
Lovely Professional University

Name : Aman Kumar


Rollno : RQ2009B40
Reg.no : 12009597
Cipla Limited
Our Inspiration for Innovation
For us at Cipla,the phrases n’patient-centricity’ and 'innovation‘ contain a rich and
permanent synergy.Our patient –centricity is innovative ,and our innovation is
always patient-centric
Our core technical operations have always been the backbone of our work.Cipla
was conceived in 1953 to manufacture world-class medicines.Our decision to
develop bulk drugs in India in the 1960s was born out of our long- term vision for
pharma in the country.Our pioneering feats in inhabitation therapy in the 1970s
was the result of our recognition of the future of respiratory medicine.We broke
new ground for the domestic pharma industry with US FDAapproval in the
1980s.In the last two decades ,we have diversified into newer therapies ,
capabilities, digitisation,automation and analytics, technology platforms,’firsts’ in
combination drugs and devices,dosages forms,geographies and strategies.44
manufacturing sites,50+ dosage forms,1500+products in 80+ markets.For us,each
of these figures is an indication of the number of lives around the world that we
touch every single day.
In turn, patient needs directly dictate our direction.It was the pain of a long- time
employee that triggered our search for a breakthrough in oral iron chelation for
thalassemia patients in India.Our single minded- fight for patient accessibility led
to our paradigm- changing offer in HIV/AIDS.The sighting of a mother’s struggle to
put together multiple components resulted in a combination devices for paediatric
asthma.We continue to maintain a business that is dedicated to bringing essential
drugs to patients in rural Africa.It is the commitment to our patients that drives us
to think out – of – the- box- every single day.
We have always viewed ourselves as a member of society.Patient
awareness campaigns, projects in Skilling and disaster response,
primary healthcare and corrective surgeries, internships and
education,all keep us rooted in the community, wherever we are
present.The next big disruptive idea could come from anyone
anywhere around the world, which is why we have taken it upon
ourselves to find, mentor and incubate the best future- shaping
business ideas in healthcare from within and outside Cipla.
Patients
*Focus on impact,and double the
number of patients we serve globally

Leadership In CoreMarkets
* Be among the top 3 in home markets
and legacy emerging markets
*Be among the fastest growth in
emerging economies and Specially
business.

Commercial Excellence
*Accelerated revenue growth and
sustainable margin expansion
Financial
Highlights
TOTAL INCOM E FROM
OPERATIONS
Operational Highlights
CSR HIGHLIGHTS
Cipla Foundation envisions and executes Viola’s Corporate Social Responsibility
In the last year ,we have reached out to over 2,20,000 individuals in the community across initiatives in Health/Education/Skilling

Health
Education
Skilling
Our people,
Our
Pride on innovative work
Our emphasis
culture Helps our One Cipla family
pursue our Purpose of 'Caring for
Life’s.
Beyond Drugs and Devices
Outcomes change when mindsets change,
be it Disruptive business ideas, dispelling
myths to Breathe freely or supporting
primary healthcare Projects around the
world.
Making Medicines, Making a
Difference
Our diverse portfolio of
drugs spread across
therapies
and geographies is the
result of our
uncompromising
Commitment to research,
quality and manufacturing
About this Report
Cipla takes pride in present in the Annual Report 2017-2018 ,with a first time
adoption of integrated reporting framework by the International Integrated
Reporting Council.Integrated reporting lays down standard which enable
companies to present stakeholders with a broader and a more comprehensive
perspective on business health & performance.Cipla being one of India’s first
adopters of integrated reporting in the pharma sector,views this report as one
more step in our legacy of pioneering advances in the pharma sector.

Leading the change


Cipla has always been ahead of the curve
when it comes to driving change.We
continuously reinvent
Ourselves to be more patient centric and to stay relevant
in the evolving business and regulatory environment.Our journey
spanning eight decades has witnessed several transformations,and is a
testimony of our ability to reinvent.Tge release of our first annual report
under the integrated reporting framework signifies Viola’s adoption of
the new standards in corporate reporting.
Cipla‘s Stakeholder Engagement Strategy

We understand the importance of fostering and maintaining a strong


engagement with our stakeholders- a crucial factor to achieve success in our
value creation journey.Our stakeholders are persons, groups or organization
directly impacted by our activities and decisions bas well as those who can
influence our operations.
Our stakeholders are categoriesd I
nto 9 groups based on the above criteria.
Cipla’s Risk Management Framework

Risk Management is one of the critical elements of Cipla’s


Operating Framework.Cipla’s Enterprise Risk Management
(ERM) framework encompasses practices relating to the
identification, evaluation, mitigation and monitoring of strategic,
operational, financial and compliance risk to achieve key
business objectives.Through the
ERM framework,we seek to minimize the adverse impact of
risks, thereby enabling effective leveraging of marketi
opportunities and enhancement of long
term competitive advantage.
At the heart of Cipla’s operations lies our business model,which determine the
way we calibrate the six capitals and transform input into outcomes to achieve
our strategic goals.Thr business model demonstrate how Cipla conduct the
business to retain our leadership position across market s.

The fundamental purpose of including Cipla business model in this report is to


provide our stallholders with an insight into the company’s strategy and it’s
ability to generate short, medium and long term value.In addition to providing on
overarching view of the Company’s value creation process,the model also
outlines the interconnectedness between the capitals is what allows us to work
in a cohesive manner,as one Cipla ,to cater to all stallholder requirements.

The business model is derived by elements critical to Cipla, encompassing the


internal and external factors influencing the company . These elements include
*our Inspiration and ethas
*The environment we operate in

You might also like